In addition, the phosphorylated TDP-43 levels in CSF or plasma are significantly higher in ALS patients than those in normal healthy controls, suggesting that p-TDP-43 is a potential diagnostic biomarker or indicator for disease progression in ALS patients [19,20,21]. Here, TARDBP is linked to amyotrophic lateral sclerosis.